Bionano Genomics (BNGO) Asset Utilization Ratio (2018 - 2026)

Bionano Genomics has disclosed Asset Utilization Ratio across 9 years of filings, most recently posting 0.42 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.42, up 13.14% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.42 (up 13.14% YoY), and the FY2025 annual result was 0.38, up 79.45% from the prior year.
• Asset Utilization Ratio came in at 0.42 for Q1 2026 at Bionano Genomics, up from 0.37 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q1 2026 to a low of 0.06 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.2 (2024), against an average of 0.23.
• Across the five-year window, Asset Utilization Ratio jumped 127.63% in 2024 and decreased 0.46% in 2025, its largest moves.
• Bionano Genomics' Asset Utilization Ratio stood at 0.09 in 2022, then jumped by 106.9% to 0.18 in 2023, then soared by 105.88% to 0.38 in 2024, then fell by 0.46% to 0.37 in 2025, then increased by 11.19% to 0.42 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.42 (Q1 2026), 0.37 (Q4 2025), and 0.37 (Q3 2025), per Business Quant data.